Abstract
In 2016, US Congress passed the 21st Century Cures Act, which provided funding to the National Cancer Institute for the Beau Biden Cancer Moonshot (hereafter, “Moonshot”). Funding for the initiative began in 2017 and is intended to continue annually for 7 years. Now that we are just beyond that halfway point, the time seems right to assess the progress of this visionary effort. Already, it is clear the Moonshot is meeting its three broad goals of accelerating scientific discovery in cancer, fostering greater collaboration, and increasing the sharing of data to improve cancer prevention, diagnosis, treatment, and care by implementing the recommendations of its advisory Blue Ribbon Panel.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
